Inventor

KADOMATSU KENJI

JP12 patents

⚠️ This page may combine multiple inventors who share the name “KADOMATSU KENJI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TAKASHI MURAMATSU

2 patents

US6572851B2Jun 3, 2003

Method for suppressing or treating drug-induced nephropathy

TAKASHI MURAMATSU27 citations89

US7309695B2Dec 18, 2007

Pharmaceutical compositions for the prevention and treatment of atherosclerosis and restenosis after PTCA

TAKASHI MURAMATSU0 citations48

HORIBA MITSURU

2 patents

US8288343B2Oct 16, 2012

Activation of endothelial nitric oxide synthase by midkine and uses therefor in effecting vasodilation

HORIBA MITSURU8 citations72

US9023799B2May 5, 2015

Method to reduce loss of cardiac function following ischemia/reperfusion

HORIBA MITSURU0 citations44

SEIKAGAKU KOGYO CO LTD

2 patents

US6037159AMar 14, 2000

Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the same

SEIKAGAKU KOGYO CO LTD11 citations71

US6455289B1Sep 24, 2002

Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the same

SEIKAGAKU KOGYO CO LTD0 citations49

UNIV NAGOYA NAT UNIV CORP

2 patents

US9840552B2Dec 12, 2017

Monoclonal antibody against human midkine

UNIV NAGOYA NAT UNIV CORP0 citations48

US8754036B2Jun 17, 2014

Method for treating neuropathic pain

UNIV NAGOYA NAT UNIV CORP0 citations43

ACADEMIA SINICA

1 patent

US11141428B2Oct 12, 2021

Octasaccharides and uses thereof

ACADEMIA SINICA0 citations51

RIBOMIC INC

1 patent

US9506070B2Nov 29, 2016

Aptamer against midkine and applications thereof

RIBOMIC INC0 citations47

MEDICAL THERAPIES LTD

1 patent

US7820160B2Oct 26, 2010

Midkine inhibitory compositions for the treatment of angiostenosis

MEDICAL THERAPIES LTD0 citations43

NAT UNIV CORP NAGOYA UNIV

1 patent

US9592279B2Mar 14, 2017

Agent for neuropathic pain

NAT UNIV CORP NAGOYA UNIV0 citations41